top of page
CGTI.png

Christopher Jewell

CSO at Cartesian Therapeutics

Dr. Jewell is the Chief Scientific Officer at Cartesian Therapeutics, a clinical stage biotech pioneering RNA-based cell therapies for autoimmunity and cancer. His expertise in bioengineering, immunology, and nanotechnology span two decades of experience, including as the MPower Professor and Minta Martin Professor at the University of Maryland, a Consultant with the Boston Consulting Group, and an advisor to dozens of drug makers. Dr. Jewell’s research has resulted in $26M in funding and 130 manuscripts and patents, including work in Nature, Nature Materials, Lancet Neurology, Nature Biotechnology, and PNAS. He has received over 50 awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE) – the nation’s highest honor for such scientists. He is an elected fellow of numerous professional societies, including the ACGT, AIMBE, BMES, and CRS. Chris completed his PhD in Chemical Engineering at the University of Wisconsin, and was a Ragon Postdoctoral Fellow at MIT and Harvard.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers
bottom of page